GCP
GSA Capital Partners’s Nuvation Bio NUVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Buy |
1,627,122
+966,070
| +146% | +$1.88M | 0.22% | 39 |
|
|
2025
Q1 | $1.16M | Buy |
661,052
+418,799
| +173% | +$737K | 0.11% | 271 |
|
|
2024
Q4 | $644K | Buy |
242,253
+167,321
| +223% | +$445K | 0.05% | 714 |
|
|
2024
Q3 | $172K | Buy |
+74,932
| New | +$172K | 0.01% | 1440 |
|
|
2024
Q1 | – | Sell |
-42,776
| Closed | -$65K | – | 1861 |
|
|
2023
Q4 | $65K | Sell |
42,776
-187,519
| -81% | -$285K | 0.01% | 1414 |
|
|
2023
Q3 | $309K | Sell |
230,295
-46,390
| -17% | -$62.2K | 0.03% | 1058 |
|
|
2023
Q2 | $498K | Sell |
276,685
-41,879
| -13% | -$75.4K | 0.05% | 739 |
|
|
2023
Q1 | $529K | Buy |
318,564
+71,023
| +29% | +$118K | 0.05% | 675 |
|
|
2022
Q4 | $475K | Buy |
247,541
+49,164
| +25% | +$94.3K | 0.06% | 631 |
|
|
2022
Q3 | $444K | Buy |
198,377
+163,635
| +471% | +$366K | 0.06% | 659 |
|
|
2022
Q2 | $113K | Buy |
+34,742
| New | +$113K | 0.02% | 1201 |
|